Sectors
FBIO
Fortress Biotech, Inc.
2.51
2 x 1.74
2 x 3.20
bid
ask
+
0.00
0.00%
2 @ 07:54 PM
2.53 +0.02 (0.80%)
| Ytd | -31.42% | |
| 1y | -29.49% |
2.47
day range
2.56
2.18
52 week range
4.53
| Open | 2.50 | Prev Close | 2.51 | Low | 2.47 | High | 2.56 | Mkt Cap | 83.71M |
| Vol | 414.78K | Avg Vol | 566.53K | EPS | 2.77 | P/E | 0.91 | Forward P/E | -0.99 |
| Beta | 1.75 | Short Ratio | 4.57 | Inst. Own | 15.78% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.94 | 200-d Avg | 3.00 | 1yr Est | 14.33 |
| Income Statement | |||
| Total Revenue | 18.72M | ||
| Revenues (USD) | 18.72M | ||
| Cost of Revenue | 6.14M | ||
| Gross Profit | 12.58M | ||
| Operating Expenses | 22.58M | ||
| Research and Development Expense | 805.00K | ||
| Selling, General and Administrative Expense | 20.81M | ||
| Operating Income | -10.01M | ||
| Interest Expense | 1.48M | ||
| Income Tax Expense | 320.00K | ||
| Net Income | -468.00K | ||
| Net Income Common Stock | -2.48M | ||
| Net Income Common Stock (USD) | -2.48M | ||
| Consolidated Income | 602.00K | ||
| Net Income to Non-Controlling Interests | 1.07M | ||
| Earnings per Basic Share | -0.08 | ||
| Earnings per Basic Share (USD) | -0.08 | ||
| Earnings per Diluted Share | -0.08 | ||
| Earning Before Interest & Taxes (EBIT) | 1.33M | ||
| Earning Before Interest & Taxes (USD) | 1.33M | ||
| Preferred Dividends Income Statement Impact | 2.01M | ||
| Weighted Average Shares | 31.79M | ||
| Weighted Average Shares Diluted | 31.79M | ||
| Balance Sheet | |||
| Cash and Equivalents | 197.80M | ||
| Cash and Equivalents (USD) | 197.80M | ||
| Investments | 29.45M | ||
| Investments Non-Current | 29.45M | ||
| Trade and Non-Trade Receivables | 36.75M | ||
| Current Assets | 245.51M | ||
| Property, Plant & Equipment Net | 13.77M | ||
| Total Assets | 316.71M | ||
| Debt Current | 7.25M | ||
| Total Debt | 53.32M | ||
| Current Liabilities | 62.02M | ||
| Debt Non-Current | 46.07M | ||
| Total Liabilities | 110.63M | ||
| Accumulated Retained Earnings (Deficit) | -624.15M | ||
| Shareholders Equity | 164.14M | ||
| Shareholders Equity (USD) | 164.14M | ||
| Assets Non-Current | 71.21M | ||
| Total Debt (USD) | 53.32M | ||
| Goodwill and Intangible Assets | 25.51M | ||
| Inventory | 8.16M | ||
| Liabilities Non-Current | 48.61M | ||
| Trade and Non-Trade Payables | 49.33M | ||
| Tax Liabilities | 5.18M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.53M | ||
| Net Cash Flow from Financing | 91.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -59.26M | ||
| Capital Expenditure | -79.00K | ||
| Issuance (Purchase) of Equity Shares | 74.00K | ||
| Net Cash Flow from Investing | -79.00K | ||
| Net Cash Flow from Operations | -59.28M | ||
| Share Based Compensation | 2.88M | ||